Human ABCA1 Virus-Like Particles

ATP-binding cassette transporter A1 (ABCA1) is a key membrane protein that plays a crucial role in cellular cholesterol efflux and high-density lipoprotein (HDL) biosynthesis. As a member of the ATP-binding cassette transporter (ABC) family, ABCA1 facilitates the transfer of phospholipids and cholesterol from cells to apolipoprotein A-I (apoA-I) to form nascent HDL particles. This process is crucial for reverse cholesterol transport (RCT), a mechanism that clears excess cholesterol from peripheral tissues and delivers it to the liver for excretion. Mutations in the ABCA1 gene are associated with Tangier disease, a rare genetic disorder characterized by severely reduced HDL levels and tissue accumulation of cholesterol, which increases the risk of cardiovascular disease. Beyond lipid metabolism, ABCA1 is also involved in regulating immune responses, inflammation, and neurodegenerative diseases. Given its central role in maintaining lipid homeostasis, ABCA1 has emerged as a promising therapeutic target for atherosclerosis and other metabolic disorders.

ABCA1 virus-like particles (VLPs) are non-infectious nanostructures designed to mimic the structural and functional properties of the ABCA1 protein while incorporating the self-assembling properties of the viral capsid. VLPs are typically composed of recombinant ABCA1 or its domains conjugated to viral envelope proteins or lipids, enabling them to form stable, uniform particles that resemble the native virus but lack viral genetic material. These particles provide a versatile platform for studying the mechanisms of ABCA1-mediated cholesterol efflux, as they can be genetically engineered to display specific functional domains or mutations for structure-function analysis. ABCA1 VLPs also hold great potential as therapeutics, particularly in the area of ​​cardiovascular disease. They can be used to deliver cholesterol-modulating compounds, enhance high-density lipoprotein (HDL) biosynthesis, or serve as immunogens to induce anti-atherosclerotic immune responses. Their biocompatibility, biodegradability, and ability to evade immune detection make them ideal candidates for drug delivery and vaccine development.